It is therefore possible that the increased in vivo glycation of PON1 leads to its glyoxidation and is responsible for the derangement of membrane hydroperoxide metabolism found in HDL from people with Type 2 diabetes and those with CHD. The gene discussed is PON1; the disease is type 2 diabetes mellitus.